Wanbang Biopharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WANBANG BIOPHARMS, and what generic and branded alternatives to WANBANG BIOPHARMS drugs are available?
WANBANG BIOPHARMS has five approved drugs.
Summary for Wanbang Biopharms
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Wanbang Biopharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wanbang Biopharms | SUNITINIB MALATE | sunitinib malate | CAPSULE;ORAL | 218012-004 | Aug 21, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Wanbang Biopharms | LEFLUNOMIDE | leflunomide | TABLET;ORAL | 077087-002 | Sep 13, 2005 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Wanbang Biopharms | MYCOPHENOLIC SODIUM | mycophenolic sodium | TABLET, DELAYED RELEASE;ORAL | 216637-001 | May 29, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Wanbang Biopharms | SUNITINIB MALATE | sunitinib malate | CAPSULE;ORAL | 218012-001 | Aug 21, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
